Welcome to our dedicated page for Ensign Group SEC filings (Ticker: ENSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ensign Group, Inc. (Nasdaq: ENSG) files detailed reports with the U.S. Securities and Exchange Commission that describe its post-acute healthcare operations, skilled nursing and senior living services, and healthcare real estate activities. This SEC filings page brings together those documents, along with AI-powered tools that help explain the information they contain.
Ensign’s current reports on Form 8-K discuss topics such as quarterly financial results, the use of non-GAAP financial measures, and changes in board composition and executive roles. In these filings, the company explains how it calculates measures like Adjusted Net Income, Adjusted Earnings per Share, EBITDA, Adjusted EBITDA, Adjusted EBITDAR, Adjusted EBT and Funds from Operations (FFO) for its Standard Bearer real estate segment. These definitions help investors understand how Ensign evaluates performance in its skilled services and real estate businesses.
Through this page, users can access Ensign’s annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K as they are made available on EDGAR. AI-generated summaries highlight key points from lengthy filings, such as segment descriptions, the role of Standard Bearer Healthcare REIT, Inc., and the company’s approach to non-GAAP metrics. The platform also surfaces relevant information from Forms 3, 4 and 5 related to equity ownership and transactions by directors and officers, giving additional context on insider activity.
By combining real-time SEC updates with AI explanations, this ENSG filings page is intended to make Ensign’s regulatory disclosures more accessible to investors who want to understand its skilled nursing, senior living and healthcare real estate operations in greater depth.
The filer submitted a Form 144 notice for the sale of 700 shares of Common stock via Fidelity Brokerage Services, with an aggregate market value of $120,442 and an approximate sale date of 09/02/2025 on NASDAQ. The shares were acquired through restricted stock vesting on 01/15/2022 (424 shares) and 04/18/2024 (276 shares) and were paid as compensation. The filing lists three prior sales by Barry Smith in the past three months: 700 shares on 06/02/2025 for $102,557, 700 shares on 07/01/2025 for $107,436, and 700 shares on 08/01/2025 for $105,000. The notice includes the standard signature representation that the seller is not aware of undisclosed material adverse information.
The Ensign Group, Inc. reported compensation actions related to the previously announced retirement of director Christopher Christensen from its Board effective September 1, 2025. The compensation committee approved the accelerated vesting, as of August 21, 2025, of 3,300 unvested restricted stock awards and 21,750 unvested stock options in the company, plus 1,000 unvested restricted stock awards in Standard Bearer Healthcare REIT, Inc.
Mr. Christensen will receive a cash bonus of $2,070,000 for services from January 1, 2025 to September 1, 2025, and a cash subsidy of up to $150,000 as prepayment for five years of health insurance premiums starting September 1, 2025. He may provide advisory services to management for up to one year at a rate not exceeding $100,000 per year. Under the Standard Bearer 2022 Omnibus Incentive Plan, the company will repurchase 19,726 Standard Bearer common shares and one preferred share from Mr. Christensen for a total of $287,393, based on third-party fair market value.
The Ensign Group director Daren Shaw reported a sale of 1,000 shares of ENSG common stock on 08/15/2025 at a price of $166.17 per share. After the reported sale Mr. Shaw beneficially owned 24,526 shares directly. The filing discloses the sale was effected under a Rule 10b5-1 trading plan adopted May 7, 2025, indicating the transaction followed a pre-established written plan. The Form 4 was signed by a power of attorney on 08/19/2025.
The Ensign Group, Inc. (ENSG) Form 144 notice reports a proposed sale of 1,000 common shares through Fidelity Brokerage Services with an aggregate market value of $166,170.00, scheduled approximately 08/15/2025 on NASDAQ. The shares were acquired via restricted stock vesting on various dates (2018 and 2025) and paid as compensation. The filer disclosed prior sales of 1,999 shares on 05/15/2025 generating $290,794.53. The notice includes the required attestation about material nonpublic information.
The Ensign Group, Inc. insider disclosed an option exercise and immediate sale by CEO and director Barry Port. The reporting person exercised 2,399 employee stock options with a $15.93 exercise price and sold 2,399 shares at $160 per share on 08/08/2025 under a Rule 10b5-1 trading plan adopted May 6, 2024.
The report shows the reporting persons direct beneficial ownership after the transactions as 57,030 shares and indirect beneficial ownership of 155,300 shares held of record by trusts for Barry R. Port and spouse Michelle Port. The underlying options were granted August 31, 2016 and vested over five equal annual installments.
The filing is a Form 144 for The Ensign Group, Inc. (ENSG) disclosing a proposed sale of 2,399 common shares. The seller intends to execute the transaction through Fidelity Brokerage Services LLC on or about 08/08/2025. Based on the filing, the shares carry an aggregate market value of $383,840, while the company has 57,700,157 shares outstanding. The securities were originally obtained via an employee stock option granted on 08/31/2016 and will be purchased for cash at exercise on the transaction date. No other sales by this individual occurred within the last three months. The notice affirms that the filer possesses no undisclosed material adverse information about the issuer.
The Ensign Group, Inc. (ENSG) filed Form 144 disclosing a planned sale of 425 common shares through Fidelity Brokerage Services LLC, expected on or after 31 Jul 2025. The shares have an estimated aggregate market value of $63,422.75 and represent an immaterial ~0.0007 % of the company’s 57.7 million shares outstanding.
The securities were originally received as restricted-stock vesting awards on 15 Jan 2021 (260 sh) and 15 Jul 2021 (165 sh) as compensation from the issuer. The filer reports no sales in the prior three months. Given the small size and routine nature of the transaction, the notice is unlikely to have a meaningful impact on ENSG’s share price but does signal a minor insider disposition.